Acinetobacter junii Cholangitis with a Metallic Biliary Stent for Palliation of Klatskin Tumor

2021 ◽  
Author(s):  
Lim Puay Khim ◽  
Thomas Zheng Jie Teng ◽  
Vishal G. Shelat
Keyword(s):  
Biliary Stent ◽  
Klatskin Tumor ◽  
Acinetobacter Junii

Su1381 Risk Factors for Cholecystitis After Bilateral Biliary Stent Placement in Patients With Klatskin Tumor

2013 ◽  
Vol 77 (5) ◽  
pp. AB304-AB305 ◽  
Author(s):  
Dae Hwan Kang ◽  
Hyung Wook Kim ◽  
Cheol Woong Choi ◽  
Young M.I. Hong ◽  
Su Jin Kim ◽  
...  
Keyword(s):  
Risk Factors ◽  
Stent Placement ◽  
Biliary Stent ◽  
Klatskin Tumor

Klatskin tumor -- Report of 15 resected cases

Chirurgie ◽  
1999 ◽  
Vol 124 (2) ◽  
pp. 132-140
Author(s):  
E SANTORO ◽  
M SACCHI ◽  
F CARBONI ◽  
R SANTORO
Keyword(s):  
Klatskin Tumor

Effect of a novel nutritional therapy in a case of Klatskin tumor

2009 ◽  
Vol 47 (05) ◽  
Author(s):  
M Figler ◽  
Ö Horváth ◽  
C Weninger ◽  
I Battyányi ◽  
P Grandics
Keyword(s):  
Nutritional Therapy ◽  
Klatskin Tumor

Biliary stent placement over a standard papillotomy knife

2011 ◽  
Vol 24 (01) ◽  
Author(s):  
A Weber ◽  
S von Delius ◽  
RM Schmid ◽  
A Meining
Keyword(s):  
Stent Placement ◽  
Biliary Stent

Modified gianturco biliary stent in benign and malignant obstruction: Results of long-term follow up

1993 ◽  
Vol 29 (3) ◽  
pp. 448
Author(s):  
Jin Young Chung ◽  
Ho Young Song ◽  
Hyun Young Han ◽  
Young Min Han ◽  
Gyung Ho Chung ◽  
...  
Keyword(s):  
Biliary Stent ◽  
Malignant Obstruction ◽  
Long Term Follow Up

THE VALUE OF SKELETAL MUSCLE MASS IN PREDICTING SHORT-TERM OUTCOMES OF SURGICAL TREATMENT FOR KLATSKIN TUMOR

2018 ◽  
Vol 64 (5) ◽  
pp. 564-569
Author(s):  
Yuriy Zharikov ◽  
Tatyana Zharikova ◽  
Vladimir Nikolenko
Keyword(s):  
Skeletal Muscle ◽  
Surgical Treatment ◽  
Muscle Mass ◽  
Skeletal Muscle Mass ◽  
Negative Impact ◽  
Treatment Algorithm ◽  
Preoperative Treatment ◽  
Klatskin Tumor ◽  
Short Term ◽  
Oncological Patients

The objective of this review study was to analyze the relationship between skeletal muscle mass and postoperative short-term outcomes morbidity in patients with Klatskin tumor who underwent surgical treatment. Low index skeletal muscle mass had a negative impact factor on postoperative morbidity following resection of Klatskin tumor and should therefore be considered as preoperative risk assessment. The further study of body composition in oncological patients allowed revealing the group of patients with high probability of postoperative complications and this factor needed to be added to future models predictive scale of short-term outcomes with the aim of making the most rational preoperative treatment algorithm.

scholarly journals Disposable digital percutaneous cholangioscope-aided retrieval of a plastic biliary stent after failed retrieval at ERCP

VideoGIE ◽  
2021 ◽  
Author(s):  
Sooraj Tejaswi ◽  
Rex M. Pillai ◽  
Sirisha Grandhe ◽  
Dhairyasheel Patel ◽  
Zachary B. Jenner
Keyword(s):  
Biliary Stent

scholarly journals A85 THE CLINICAL IMPACT OF COVID-19 DELAYS ON PLASTIC BILIARY STENT REMOVAL IN NOVA SCOTIA

2021 ◽  
Vol 4 (Supplement_1) ◽  
pp. 54-56
Author(s):  
D R Lim ◽  
M Tsai ◽  
S E Gruchy ◽  
J Jones ◽  
G Williams ◽  
...  
Keyword(s):  
Survival Analysis ◽  
Nova Scotia ◽  
Stent Placement ◽  
Biliary Stent ◽  
Biliary Stents ◽  
Stent Occlusion ◽  
Stent Removal ◽  
Kaplan Meier ◽  
And Migration

Abstract Background The COVID-2019 pandemic continues to restrict access to endoscopy, resulting in delays or cancellation of non-urgent endoscopic procedures. A delay in the removal or exchange of plastic biliary stents may lead to stent occlusion with consensus recommendation of stent removal or exchange at three-month intervals [1–4]. We postulated that delayed plastic biliary stent removal (DPBSR) would increase complication rates. Aims We aim to report our single-centre experience with complications arising from DPBSR. Methods This was a retrospective, single-center, observational cohort study. All subjects who had ERCP-guided plastic biliary stent placement in Halifax, Nova Scotia between Dec 2019 and June 2020 were included in the study. DPBSR was defined as stent removal >=90 days from insertion. Four endpoints were assigned to patients: 1. Stent removed endoscopically, 2. Died with stent in-situ (measured from stent placement to documented date of death/last clinical encounter before death), 3. Pending removal (subjects clinically well, no liver enzyme elevation, not expired, endpoint 1 Nov 2020), and 4. Complication requiring urgent reintervention. Kaplan-Meier survival analysis was used to represent duration of stent patency (Fig.1). Results 102 (47.2%) had plastic biliary stents placed between 2/12/2019 and 29/6/2020. 49 (48%) were female, and the median age was 68 (R 16–91). Median follow-up was 167.5 days, 60 (58.8%) subjects had stent removal, 12 (11.8%) died before replacement, 21 (20.6%) were awaiting stent removal with no complications (median 230d, R 30–332), 9 (8.8%) had complications requiring urgent ERCP. Based on death reports, no deaths were related to stent-related complications. 72(70.6%) of patients had stents in-situ for >= 90 days. In this population, median time to removal was 211.5d (R 91-441d). 3 (4.2%) subjects had stent-related complications requiring urgent ERCP, mean time to complication was 218.3d (R 94–441). Stent removal >=90 days was not associated with complications such as occlusion, cholangitis, and migration (p=1.0). Days of stent in-situ was not associated with occlusion, cholangitis, and migration (p=0.57). Sex (p=0.275), cholecystectomy (p=1.0), cholangiocarcinoma (p=1.0), cholangitis (p=0.68) or pancreatitis (p=1.0) six weeks prior to ERCP, benign vs. malignant etiology (p=1.0) were not significantly associated with stent-related complications. Conclusions Plastic biliary stent longevity may have been previously underestimated. The findings of this study agree with CAG framework recommendations [5] that stent removal be prioritized as elective (P3). Limitations include small sample size that could affect Kaplan-Meier survival analysis. Despite prolonged indwelling stent time as a result of COVID-19, we did not observe an increased incidence of stent occlusion or other complications. Funding Agencies None

Sign in / Sign up

Export Citation Format

Share Document